Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

BACKGROUND: The efficacy and safety of Lisdexamfetamine dimesylate (LDX) in the treatment of moderate to severe binge eating disorder (BED) has been demonstrated in multiple randomised clinical trials. Despite this, little is known about how LDX acts to improve binge eating symptoms. This study aims...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Eat Disord
Egile Nagusiak: Griffiths, Kristi R., Yang, Jenny, Touyz, Stephen W., Hay, Phillipa J., Clarke, Simon D., Korgaonkar, Mayuresh S., Gomes, Linette, Anderson, Gail, Foster, Sheryl, Kohn, Michael R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6621979/
https://ncbi.nlm.nih.gov/pubmed/31333843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40337-019-0253-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak